Genestra Brands TOS Cal Hydroxy
Natural health product licensed in Canada
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80030570
- Status
- Active licence
- Licence date
- 16 March 2012
- Revision date
- 21 November 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vanadium Source : Malate de vanadium | 25 mcg | Not calculated |
| Vanadium Source : Fumarate de vanadium | 25 mcg | Not calculated |
| Vanadium Source : Glutarate de vanadium | 25 mcg | Not calculated |
| Vanadium Source : Succinate de vanadium | 25 mcg | Not calculated |
| Vanadium Source : Citrate de vanadium | 25 mcg | Not calculated |
| Calcium Source : Microcrystalline hydroxyapatite | 125 mg | 500,000 µg |
| Calcium Source : Dibasic calcium phosphate | 125 mg | 500,000 µg |
| Calcium Source : Carbonate de calcium | 125 mg | 500,000 µg |
| Phosphore Source : Microcrystalline hydroxyapatite | 62.5 mg | 250,000 µg |
| Phosphore Source : Dibasic calcium phosphate | 62.5 mg | 250,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 100 UI | 2.5 mcg | 10 µg |
Non-medicinal ingredients
Hypromellose, Microcrystalline cellulose, silice, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps in the development and maintenance of bones and teeth. Helps the body to metabolize carbohydrates, fats and proteins and helps in the absorption and use of Calcium and phosphorus. Helps in tissue formation and helps to maintain proper muscle function. Helps to prevent molybdenum deficiency. Calcium intake, when combined with sufficient vitamin D, a healthy diet and regular exercise, may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80030570
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging